Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The one analyst offering a 12 month price target expects Virpax Pharmaceuticals Inc share price to rise to 3.00 in the next year from the last price of 0.7064.
High | 324.7% | 3.00 |
Med | 324.7% | 3.00 |
Low | 324.7% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +10.69% |
Average growth rate | +29.89% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼